ophthalmologyadvisor11h
In Diabetic Eye Disease, Loss to Follow-Up Linked With Race, Distance From Care
Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.
Too Old to Operate13h
Glucose-Lowering Mechanisms of PPARG in Diabetic Retinopathy
The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...
nationthailand16h
Google, Perceptra offer AI-powered diabetic retinopathy screening
Google and Perceptra, a Google technology licensing partner, are joining forces to provide AI-powered diabetic-retinopathy (DR) screening to around 1 million people in underserved communities across ...
Mitochondria's role in diabetes: Could reversing damage offer a cure?
Regardless of the cell type, the researchers found that damage to the mitochondria did not cause cell death. This observation ...
PipelineReview.com5d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) – ...
PharmiWeb5d
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...